|
Market Closed -
Nasdaq
21:00:00 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 127.81 USD | +0.46% |
|
+6.37% | +29.40% |
| 08-20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 08-20 | Canaccord Genuity Initiates Incyte at Buy With $152 Price Target | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- INCY Stock
- Consensus Incyte Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
